ArticleWorld journal of surgical oncology2025
Comparing survival outcomes between surgical and non-surgical treatments in patients with early-onset endometrial cancer and developing a nomogram to predict survival: a study based on Eastern and Western data sets.
Article in World journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Unveiling the mysteries of C1QBP in gynecological tumors (Review).Molecular and clinical oncology · 2026Review
- Remodeling the tumor microenvironment: regulatory effects of β-sitosterol and luteolin on the immunosuppressive milieu in endometrial carcinoma and implications for combinatorial immunotherapy.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSurgery is the preferred approach for treating endometrial cancer (EC). However, the prognosis of young women undergoing surgery has not been thoroughly evaluated. This study aims to establish a prognostic nomogram for predicting overall survival (OS) in postoperative patients with early-onset endometrial cancer (EOEC), facilitating risk stratification for high-risk patients.
methodsPatients diagnosed with EOEC during 2004-2015 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. The nomogram of OS was established according to the multivariate Cox regression analyses. The prediction accuracy and clinical net benefit of the model were assessed by the concordance index (C-index), receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA). Additionally, external validation was performed with 230 EOEC patients who underwent primary surgical treatment at the First Affiliated Hospital of Chongqing Medical University from 2013 to 2018.
resultsThe mean survival period in the surgical group of EOEC was 87.62 months (range: 86.92-88.32), compared to 64.00 months (range: 55.05-72.96) in the non-surgical group. Compared with the non-surgical group, patients who underwent surgery had better outcomes. A total of 4345 eligible postoperative patients with EOEC were identified and enrolled in this study. Multivariate Cox analysis showed that age, race, grade, T stage, tumor size, and lymphadenectomy were significantly associated with the prognosis of EOEC, which were further incorporated to construct a nomogram. C-index and DCA showed the predictive capability and the clinical applicability of the nomogram was superior over the TNM stage and SEER stage. Furthermore, the external validation using the FAHCQMU cohort consistently demonstrated good predictive accuracy.
conclusionsGenerally, we developed a novel nomogram model by comprehensively integrating multiple risk factors, which accurately predicts the clinical prognosis of EOEC patients after surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.